BUROSUMAB-TWZA: 5,159 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
5,159
Total FAERS Reports
27 (0.5%)
Deaths Reported
311
Hospitalizations
5,159
As Primary/Secondary Suspect
8
Life-Threatening
16
Disabilities
Prescription
Status
FDA Application: 761068 ·
First Report: 20090101 · Latest Report: 20250914
What Are the Most Common BUROSUMAB-TWZA Side Effects?
#1 Most Reported
Inappropriate schedule of product administration
579 reports (11.2%)
#2 Most Reported
Blood phosphorus decreased
509 reports (9.9%)
#3 Most Reported
Product dose omission issue
475 reports (9.2%)
All BUROSUMAB-TWZA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Inappropriate schedule of product administration | 579 | 11.2% | 0 | 20 |
| Blood phosphorus decreased | 509 | 9.9% | 0 | 26 |
| Product dose omission issue | 475 | 9.2% | 1 | 24 |
| Arthralgia | 285 | 5.5% | 1 | 16 |
| Pain | 279 | 5.4% | 0 | 15 |
| Pain in extremity | 272 | 5.3% | 0 | 8 |
| Headache | 226 | 4.4% | 0 | 11 |
| Restless legs syndrome | 217 | 4.2% | 1 | 4 |
| Incorrect dose administered | 215 | 4.2% | 0 | 10 |
| Injection site pain | 205 | 4.0% | 0 | 1 |
| Fatigue | 189 | 3.7% | 0 | 10 |
| Contraindicated product administered | 175 | 3.4% | 3 | 11 |
| Bone pain | 162 | 3.1% | 0 | 2 |
| Covid-19 | 148 | 2.9% | 2 | 13 |
| Back pain | 146 | 2.8% | 0 | 9 |
| Pyrexia | 140 | 2.7% | 0 | 12 |
| Product dose omission | 137 | 2.7% | 0 | 3 |
| Injection site pruritus | 132 | 2.6% | 0 | 1 |
| Injection site erythema | 122 | 2.4% | 0 | 1 |
| Tooth abscess | 104 | 2.0% | 0 | 6 |
Who Reports BUROSUMAB-TWZA Side Effects? Age & Gender Data
Gender: 66.0% female, 34.0% male. Average age: 33.0 years. Most reports from: US. View detailed demographics →
Is BUROSUMAB-TWZA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2009 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 0 |
| 2011 | 3 | 0 | 0 |
| 2013 | 2 | 0 | 0 |
| 2015 | 2 | 0 | 0 |
| 2016 | 8 | 0 | 0 |
| 2017 | 3 | 0 | 0 |
| 2018 | 200 | 2 | 9 |
| 2019 | 535 | 2 | 32 |
| 2020 | 698 | 3 | 45 |
| 2021 | 652 | 3 | 55 |
| 2022 | 475 | 5 | 38 |
| 2023 | 274 | 1 | 26 |
| 2024 | 287 | 2 | 14 |
| 2025 | 137 | 0 | 9 |
What Is BUROSUMAB-TWZA Used For?
| Indication | Reports |
|---|---|
| Hereditary hypophosphataemic rickets | 3,896 |
| Product used for unknown indication | 979 |
| Hypophosphataemia | 109 |
| Hypophosphataemic osteomalacia | 101 |
| Phosphorus metabolism disorder | 88 |
| Osteomalacia | 41 |
| Rickets | 18 |
| Albright's disease | 5 |
| Hypopituitarism | 5 |
| Mineral metabolism disorder | 5 |
BUROSUMAB-TWZA vs Alternatives: Which Is Safer?
BUROSUMAB-TWZA vs BUSPIRONE
BUROSUMAB-TWZA vs BUSULFAN
BUROSUMAB-TWZA vs BUSULFEX
BUROSUMAB-TWZA vs BUTALBITAL
BUROSUMAB-TWZA vs BUTENAFINE
BUROSUMAB-TWZA vs BUTORPHANOL
BUROSUMAB-TWZA vs BUTRANS
BUROSUMAB-TWZA vs BUTYLSCOPOLAMINE
BUROSUMAB-TWZA vs BYDUREON
BUROSUMAB-TWZA vs BYETTA
Official FDA Label for BUROSUMAB-TWZA
Official prescribing information from the FDA-approved drug label.